Development of robust quantitative structure-activity relationship models for cyp2c9, cyp2d6, and cyp3a4 catalysis and inhibition

23Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Cytochrome P450 enzymes are responsible for the metabolism of >75% of marketed drugs, making it essential to identify the contributions of individual cytochromes P450 to the total clearance of a new candidate drug. Overreliance on one cytochrome P450 for clearance levies a high risk of drug-drug interactions; and considering that several human cytochrome P450 enzymes are polymorphic, it can also lead to highly variable pharmacokinetics in the clinic. Thus, it would be advantageous to understand the likelihood of new chemical entities to interact with the major cytochrome P450 enzymes at an early stage in the drug discovery process. Typical screening assays using human liver microsomes do not provide sufficient information to distinguish the specific cytochromes P450 responsible for clearance. In this regard, we experimentally assessed the metabolic stability of ∼5000 compounds for the three most prominent xenobiotic metabolizing human cytochromes P450, i.e., CYP2C9, CYP2D6, and CYP3A4, and used the data sets to develop quantitative structure-activity relationship models for the prediction of high-clearance substrates for these enzymes. Screening library included the NCATS Pharmaceutical Collection, comprising clinically approved low-molecular-weight compounds, and an annotated library consisting of drug-like compounds. To identify inhibitors, the library was screened against a luminescence- based cytochrome P450 inhibition assay; and through cross referencing hits from the two assays, we were able to distinguish substrates and inhibitors of these enzymes. The best substrate and inhibitor models (balanced accuracies ∼0.7), as well as the data used to develop these models, have been made publicly available (https:// opendata.ncats.nih.gov/adme) to advance drug discovery across all research groups.

Cite

CITATION STYLE

APA

Gonzalez, E., Jain, S., Shah, P., Torimoto-Katori, N., Zakharov, A., Nguyen, D. T., … Xu, X. (2021). Development of robust quantitative structure-activity relationship models for cyp2c9, cyp2d6, and cyp3a4 catalysis and inhibition. Drug Metabolism and Disposition, 49(9), 822–832. https://doi.org/10.1124/dmd.120.000320

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free